September 23, 2014 9:42 AM ET

Biotechnology

Company Overview of Enchira Biotechnology Corporation

Company Overview

In January 2003, Enchira Biotechnology Corporation’s stockholders approved the plan of complete liquidation and dissolution of the company. Previously, it was a drug discovery and development company that was engaged in development of therapeutic proteins to inhibit receptor tyrosine kinases and their role in certain types of cancer.

4200 Research Forest Drive

The Woodlands, TX 77381

United States

28 Employees

Phone:

281-419-7000

Key Executives for Enchira Biotechnology Corporation

Enchira Biotechnology Corporation does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Rubicon Genomics, Inc. United States
InflammaGen, Inc. United States
LC Sciences, LLC United States
Sequella, Inc. United States
Layton BioScience United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Enchira Biotechnology Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.